Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart

British Journal of Pharmacology

Volumn 117, Issue 6, 1996, Pages 1261-1269

  Chi, Liguo ^a   Park, James L ^a   Friedrichs, Gregory S ^a   Banglawala, Yasmin A ^a   Perez, Maria A ^a   Tanhehco, Elaine J ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Arrhythmia; Chemical defibrillation; Class III antiarrhythmics; K(ATP) regulated channel blocker; Myocardial ischaemia; Potassium currents

Indexed keywords

ANTIARRHYTHMIC AGENT; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; TEDISAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ELECTROSTIMULATION; HEART ATRIUM MUSCLE; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HYPOXIA; INOTROPISM; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT; REOXYGENATION; SINUS RHYTHM;

EID: 0029919612     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16724.x     Document Type: Article

References (46)

1. ADAIKAN, G., BEATCH, G.N. LEE, T.L., RATNAM, S.S. & WALKER, M.J.A. (1992). Antiarrhythmic actions of tedisamil: Studies in rats and primates. Cardiovasc. Drugs Ther., 6, 345-352.
2. ARENA, J.P. & KASS, R.S. (1989). Enhancement of potassium-sensitive current in heart cells by pinacidil: Evidence for modulation of the ATP-sensitive potassium channel. Circ. Res., 65, 436-445.
3. BASKIN, E.P., SERIK, C.M., WALLACE, A.A., BROOKES, L.M., SELNICK, H.G., CLAREMON, D.A. & LYNCH, J.J. (1991). Effects of new and potent methanesulfonanilide class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscle. J. Cardiovasc. Pharmacol., 18, 406-414.
4. + current blocker. Br. J. Pharmacol., 102, 13-18.
5. BEATCH, G.N., MACLEOD, B.A., ABRAHAM, S. & WALKER, M.J.A. (1990). The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798. Proc. West Pharmacol. Soc., 33, 5-8.
6. BRAY, K. & QUAST, U. (1992). Differential inhibition by tedisamil (KC 8857) and glibenclamide of the responses to cromakalim and minoxidil sulphate in rat isolated aorta. Naunyn Schmied. Arch. Pharmacol., 345, 244-250.
7. BRIL, A., LANDAIS, L. & GOUT, B. (1993). Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo. Cardiovasc. Drugs Ther., 7, 233-240.
8. BUSCHMANN, G., WALKER, M.J.A., KUHL, U.G., VARCHMIN, G. & ZIEGLER, D. (1989). Species differences in the ECG effects of tedisamil (abstr). Naunyn. Schmied. Arch. Pharmacol. (Suppl)., 339, R61.
9. CARMELIET, E. (1992a). Potassium channels in cardiac cells. Cardiovasc. Drugs Ther., 6, 305-312.
10. + current in cardiac myocytes by dofetilide. J. Pharmacol. Exp. Ther., 262, 809-817.
11. + current in rabbit ventricular myocytes. Cardiovasc. Drugs Ther., 7, 599-604.
12. CHI, L., BLACK, S.C., KUO, P.I., FAGBEMI, S.O. & LUCCHESI, B.R. (1993). Actions of pinacidil at a reduced potassium concentration: A direct cardiac effect possibly involving the ATP-dependent potassium channel. J. Cardiovasc. Pharmacol., 21, 179-190.
13. COROMILAS, J., COSTEAS, C.A., DERUYTER, B., WIT, A.L. & PETERS, N.S. (1994). Effects of pinacidil on the electrophysiologic properties of the epicardial border zone and reentrant ventricular tachycardia (abstr). Circulation, 90, I-153.
14. DE LORENZI, F., CAI, S., SCHANNE, O.F. & RUIZ PETRICH, E. (1994). Partial contribution of the ATP-sensitive K+ current to the effects of mild metabolic depression in the rabbit myocardium. Mol. Cell Biochem., 132, 133-143.
15. DI DIEGO, J.M. & ANTZELEVITCH, C. (1993). Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation, 88, 1177-1189.
16. DUCHOSAL, F. & OPIE, L.H. (1992). Potential beneficial effects of potassium channel blockade by tedisamil in isolated perfused working rat heart with coronary artery ligation. Cardiovasc. Drugs Ther., 6, 329-336.
17. + currents in mammalian cardiac and glial cells. J. Pharmacol. Exp. Ther., 254, 560-569.
18. + current in rat ventricular myocyctes. Am. J. Physiol., 257, H1746-1749.
19. + channels in mammalian cardiac myocytes. Cardiovasc. Drugs Ther., 6, 321-327.
20. FAGBEMI, S.O., CHI, L. & LUCCHESI, B.R. (1993). Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents. J. Cardiovasc. Pharmacol., 21, 709-719.
21. + channels in adult rat ventricular cells (abstr). J. Mol. Cell. Cardiol., 24, S40.
22. FRIEDRICHS, G.S., CHI, L., BLACK, S.C., MANLEY, P.J., OH, J.Y. & LUCCHESI, B.R. (1993). Antifibrillatory effects of ibutilide in the rabbit isolated heart: Mediation via ATP-dependent potassium channels. J. Pharmacol. Exp. Ther., 266, 1348-1354.
23. FRIEDRICHS, G.S., CHI, L., GREEN. A.L. & LUCCHESI, B.R. (1994). Antifibrillatory effects of clofilium in the rabbit isolated heart. Br. J. Pharmacol., 113, 209-215.
24. GILES, W.R. & IMIAZUMI, Y. (1988). Comparison of potassium currents in rabbit atrial and ventricular cells. J. Physiol., 405, 123-145.
25. GILMAN, J.K., JALAL, S. & NACCARELLI, G.V. (1994). Predicting and preventing sudden death from cardiac causes. Circulation, 90, 1083-1092.
26. GROHS, J.G., FISCHER, G. & RABERGER, G. (1989). Cardiac and hemodynamic effects of the selective bradycardiac agent KC 8857 during exercise-induced myocardial ischemia. Eur. J. Pharmacol., 161, 53-60.
27. HIRAOKA, M. & KAWANO, S. (1989). Calcium-sensitive and insensitive transient outward current in rabbit ventricular myocytes. J. Physiol., 410, 187-212.
28. HONDEGHEM, L.M. & SNYDERS, D.J. (1990). Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation, 81, 686-690.
29. HOWARD, P.G., ABRAHAM, S., COURTICE, I.D. & WALKER, M.J. (1989). Further studies into the ECG effects of tedisamil (KC 8857) in rats. Proc. West Pharmacol. Soc., 32, 183.
30. JOSEPHSON, I.R., SANCHEZ-CHAPULA, J. & BROWN, A.M. (1984). Early outward current in rat ventricular cells. Circ. Res., 54, 157-172.
31. KAKEI, M., NOMA, A. & SHIBASAKI, T. (1985). Properties of adenosine triphosphate-regulated potassium channels in guinea-pig ventricular cells. J. Physiol., 363, 441-462.
32. 86Rb efflux induced by cromakalim, high potassium and noradrenaline, and on mechanical tension in rabbit isolated vascular smooth muscle. Naunyn. Schmied. Arch. Pharmacol., 345, 238-243.
33. LUCCHESI, B.R., CHI, L., FRIEDRICHS, G.S., BLACK, S.C. & UPRICHARD, A.C.G. (1993). Antiarrhythmic versus antifibrillatory actions: Inference from experimental studies. Am. J. Cardiol., 72, 25F-44F.
34. LYNCH, J.J., SANGUINETTI, M.C., KIMURA, S. & BASSETT, A.L. (1992). Therapeutic potential of modulating potassium currents in the diseased myocardium. FASEB. J., 6, 2952-2960.
35. MITROVIC, V., OEHM, E., LIEBRICH, A., THORMANN, J. & SCHLEPPER, M. (1992). Hemodynamic and antiischemic effects of tedisamil in humans. Cardiovasc. Drugs Ther., 6, 353-360.
36. NAKAYA, H., TOHSE, N., TAKEDA, Y. & KANNO, M. (1993). Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Br. J. Pharmacol., 109, 157-163.
37. + channels in cardiac muscle. Nature, 305, 147-148.
38. RABERGER, G., GROHS, J.G. & FISCHER, G. (1992). Antiischemic effects of tedisamil in conscious dogs. Cardiovasc. Drugs Ther., 6, 337-343.
39. REES, S.A. & CURTIS, M.J. (1993). Specific Ik1 blockade: A new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit and primate. Circulation, 87, 1979-1989.
40. SAGER, P.T., NADEMANEE, K., ANTIMISIARIS, M., PACIFICO, A., PRUITT, C., GODFREY, R. & SINGH, B.N. (1993). Antiarrhythmic effects of selective prolongation of refractoriness: Electrophysiologic actions of sematilide HCl in humans. Circulation, 88, 1072-1082.
41. SANGUINETTI, M.C. (1992). Modulation of potassium channels by antiarrhythmic and antihypertensive drugs. Hypertension, 19, 228-236.
42. + current. Differential sensitivity to block by Class III antiarrhythmic agents. J. Gen. Physiol., 96, 195-215.
43. THORMANN, J., MITROVIC, V., RIEDEL, H., NEUZNER, J., STRASSER, R., BAHAVAR, H. & SCHLEPPER, M. (1993). Tedisamil (KC 8857) is a new specific bradycardiac drug: Does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease. Am. Heart J., 125, 1233-1246.
44. to blockade? J. Cardiovasc. Pharmacol., 18, 445-456.
45. UPRICHARD, A.C.G. & LUCCHESI, B.R. (1994). The efficacy of antiarrhythmic drugs as antifibrillatory agents. In Electropharmacological Control of Cardiac Arrhythmias. ed. Singh, B., Wellens, H.J.J. & Hiraoka, M., pp. 291-312. Mount Kisco, NY: Futura Publishing Company Inc.
46. WALLACE, A.A., STUPIENSKI, R.F., BASKIN, E.P., APPLEBY, S.D., KOTHSTEIN, T., GEHRET, J.R., KING, S.W., REMY, D.C. & LYNCH, J.J. (1995). Cardiac electrophysiologic and antiarrhythmic actions of tedisamil. J. Pharmacol. Exp. Ther., 273, 168-175.